- Home
- IRMD vs ARCT Comparison
IRMD vs ARCT Comparison
Compare IRMD & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- ARCT
- Stock Information
- Founded
- IRMD 1992
- ARCT 2013
- Country
- IRMD United States
- ARCT United States
- Employees
- IRMD N/A
- ARCT N/A
- Industry
- IRMD Medical/Dental Instruments
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- IRMD Health Care
- ARCT Health Care
- Exchange
- IRMD Nasdaq
- ARCT Nasdaq
- Market Cap
- IRMD 910.4M
- ARCT 526.5M
- IPO Year
- IRMD 2014
- ARCT N/A
- Fundamental
- Price
- IRMD $83.83
- ARCT $7.11
- Analyst Decision
- IRMD Strong Buy
- ARCT Buy
- Analyst Count
- IRMD 1
- ARCT 11
- Target Price
- IRMD $72.00
- ARCT $38.67
- AVG Volume (30 Days)
- IRMD 79.7K
- ARCT 2.2M
- Earning Date
- IRMD 11-03-2025
- ARCT 11-10-2025
- Dividend Yield
- IRMD 0.81%
- ARCT N/A
- EPS Growth
- IRMD 13.00
- ARCT N/A
- EPS
- IRMD 1.65
- ARCT N/A
- Revenue
- IRMD $80,511,268.00
- ARCT $97,601,000.00
- Revenue This Year
- IRMD $12.93
- ARCT N/A
- Revenue Next Year
- IRMD $11.26
- ARCT $26.81
- P/E Ratio
- IRMD $51.13
- ARCT N/A
- Revenue Growth
- IRMD 12.91
- ARCT N/A
- 52 Week Low
- IRMD $47.48
- ARCT $7.26
- 52 Week High
- IRMD $87.88
- ARCT $24.17
- Technical
- Relative Strength Index (RSI)
- IRMD 61.23
- ARCT 26.27
- Support Level
- IRMD $82.64
- ARCT $7.93
- Resistance Level
- IRMD $87.26
- ARCT $9.29
- Average True Range (ATR)
- IRMD 3.21
- ARCT 0.54
- MACD
- IRMD -0.06
- ARCT -0.00
- Stochastic Oscillator
- IRMD 73.86
- ARCT 2.15
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.